The Optimal Volume of Medicinal Solution in the Portable Disposable Infusion Pump (SUREFUSER®A) for FOLFOX6, FOLFIRI Therapy of Colorectal Cancer Patients

Oxaliplatin, established as a therapeutic standard globally for advanced/recurrent colorectal cancer, was approved in Japan in April 2005. With this approval the FOLFOX and FOLFIRI regimens are often selected now as 1st or 2nd line treatment for advanced/recurrent colorectal cancer. Patients receivi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	YAKUGAKU ZASSHI 2009/03/01, Vol.129(3), pp.359-364
Hauptverfasser:	KAWABATA, Yoshinori, NAKAGAWA, Akiko, UCHIKOSHI, Hide, TAMIYA, Yoichi
Format:	Artikel
Sprache:	jpn
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - administration & dosage Camptothecin - administration & dosage Camptothecin - analogs & derivatives colorectal cancer Colorectal Neoplasms - drug therapy Disposable Equipment Drug Dosage Calculations Fluorouracil - administration & dosage FOLFIRI FOLFOX Home Care Services Humans Infusion Pumps Infusions, Intravenous Leucovorin - administration & dosage Organoplatinum Compounds - administration & dosage Oxaliplatin Solutions Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!